Journal Articles
Sheppard, Rochelle, Anstey, Christopher, Hanjani, Leila, Ladwa, Rahul, Berry, Robin, Fletcher, James and Hubbard, Ruth (2026). Tolerability of immune checkpoint inhibitors for cancer treatment in frail, older patients. Journal of Geriatric Oncology, 17 (2) 102829. doi: 10.1016/j.jgo.2025.102829
Quéreux, G., Rischin, D., Porceddu, S., Day, F., Brungs, D., Christie, H., Jackson, J.E., Stein, B., Su, Y.B., Ladwa, R., Adams, G., Bowyer, S.E., Otty, Z., Yamazaki, N., Bossi, P., Challapalli, A., Hauschild, A., Dréno, B., Beylot-Barry, M., Trabelsi Messai, S., Enquebecq, M., Mortier, L., Saiag, P., Montaudié, H., Neidhardt-Berard, E.M., Duval-Modeste, A.B., Jeudy, G., Basset-Seguin, N., Yoo, S.Y. ... Robert, C. (2025). Étude randomisée de phase 3 comparant le cémiplimab adjuvant à un placebo et analyse des tumeurs primaires secondaires (TPS) dans le carcinome épidermoïde cutané à haut risque (CEC) : l’essai C-POST. Annales de Dermatologie et de Vénéréologie - FMC, 5 (8), A385-A386. doi: 10.1016/j.fander.2025.09.628
Lester, Georgia M., Timmer, Barbra H. B., Wilson, Wayne J. and Ladwa, Rahul M. (2025). Where are audiologists in the room of wizards? Oncology patient experiences with audiology in an Australian public hospital. Journal of Cancer Survivorship. doi: 10.1007/s11764-025-01929-8
Ladwa, Rahul, McLean, Luke S, McGrath, Margaret and Liu, Jia (2025). The evolving role of Immune Checkpoint Inhibitors in Cutaneous Squamous Cell Carcinoma: across the disease spectrum. EJC Skin Cancer, 3 100767, 100767. doi: 10.1016/j.ejcskn.2025.100767
Ladwa, Rahul, Lee, Jenny H., McGrath, Margaret, Cooper, Caroline, Liu, Howard, Bowman, James, Gupta, Ruta, Cuscaden, Claire, Nottage, Michelle, Clark, Jonathan R., Le, Dieu, Pauley, Marketa, Kulasinghe, Arutha, Gonzalez-Cruz, Jazmina, Porceddu, Sandro V., Hughes, Brett G.M. and Panizza, Benedict (2025). Response-adapted surgical and radiotherapy de-escalation in resectable cutaneous squamous cell cancer using pembrolizumab: the De-Squamate study. Journal of Clinical Oncology, 43 (26) JCO-25-00387, 2888-2896. doi: 10.1200/jco-25-00387
Ruiz, Emily S., Muñoz-Couselo, Eva, Montaudié, Henri, Berciano-Guerrero, Miguel Angel, de la Gala, Maria del Carmen Álamo, Charles, Julie, Quéreux, Gaëlle, Nardin, Charlée, Tur, Ricardo Yaya, Dalle, Stéphane, Beylot-Barry, Marie, Ladwa, Rahul, McGrath, Margaret, Brungs, Daniel, Harris, Dean, Shue, Hong, Tazbirkova, Andrea, Fourie, Samuel, Malan, Daniel R., Oliviero, James, Wilcoxen, Lauren Neighbours, Gray, W. Garrett and Clingan, Philip (2025). Efficacy and safety of cosibelimab in advanced cutaneous squamous cell carcinoma: Results from a Pivotal Open-label Study with a median follow-up of ≥2 years. Journal of the American Academy of Dermatology, 94 (1), 48-56. doi: 10.1016/j.jaad.2025.09.009
Tan, Chin Wee, Berrell, Naomi, Donovan, Meg L., Monkman, James, Lawler, Clara, Sadeghirad, Habib, Naei, Vahid Yaghoubi, Chen, Jinjin, Rossenbloom, Alyssa, Bonnett, Shilah, Conner, Mark, Filanoski, Brian, Kang, Christine, Beechem, Joseph M., Fraser, John F., Barnett, Catherine, Ladwa, Rahul, Hughes, Brett G. M. and Kulasinghe, Arutha (2025). The development of a high-plex spatial proteomic methodology for the characterisation of the head and neck tumour microenvironment. NPJ Precision Oncology, 9 (1) 191. doi: 10.1038/s41698-025-00963-0
Burge, Matthew E., Espinoza, David, Sjoquist, Katrin Marie, Sui, Derrick HW, Mercieca-Bebber, Rebecca, Chantrill, Lorraine A., Karapetis, Christos Stelios, Steer, Christopher B., Yip, Sonia, Cuff, Jeff, Winata, Stephanie, Tie, Jeanne, Thaker, Darshit Arunbhai, Srivastav, Ratnesh, Abdi, Ehtesham, Strickland, Andrew, Segelov, Eva, Francesconi, Alessandra, Price, Timothy, Ladwa, Rahul, Joubert, Warren and Tebbutt, Niall C. (2025). AGITG MONARCC: A randomized phase 2 study of panitumumab monotherapy and panitumumab plus 5-Fluorouracil as first-line therapy for older patients with RAS and BRAF wild type metastatic colorectal cancer. A study by the Australasian Gastro-Intestinal Trials Group (AGITG). Clinical Colorectal Cancer, 24 (2), 120-128. doi: 10.1016/j.clcc.2024.11.003
Rischin, Danny, Porceddu, Sandro, Day, Fiona, Brungs, Daniel P., Christie, Hayden, Jackson, James E., Stein, Brian N., Su, Yungpo Bernard, Ladwa, Rahul, Adams, Gerard, Bowyer, Samantha E., Otty, Zulfiquer, Yamazaki, Naoya, Bossi, Paolo, Challapalli, Amarnath, Hauschild, Axel, Lim, Annette M., Patel, Vishal A., Walker, Joanna L., De Liz Vassen Schurmann, Maite, Queirolo, Paola, Cañueto, Javier, Ferreira da Silva, Flavio Augusto, Stratigos, Alexander, Guminski, Alexander, Lin, Charles, Damian, Fernanda, Flatz, Lukas, Taylor, Anne E. ... Fury, Matthew G. (2025). Adjuvant cemiplimab or placebo in high-risk cutaneous squamous-cell carcinoma. New England Journal of Medicine, 393 (8), 774-785. doi: 10.1056/nejmoa2502449
Panizza, Benedict J., O'Leary, Stephen John, Hart, Christopher David, Diwakarla, Chandra Sai, Barnett, Catherine, Lapuerta, Pablo, Lee, John, Raines, Shane, Quigley, Tera, Wolff, Heather M., Keilty, John, Ladwa, Rahul, Porceddu, Sandro V., McGrath, Margaret, Seetharamu, Nagashree, Fua, Tsien and Rischin, Danny (2025). Randomized phase Ib clinical trial of DB-020 intratympanic injections to reduce high-dose cisplatin ototoxicity. Journal of Clinical Oncology, 43 (19), 2155-2163. doi: 10.1200/jco.24.00905
Jackson, Christopher C., Liu, Jia (Jenny), Liu, Howard Y., Williams, Steven G., Anees, Asim, Noor, Zainab, Lucas, Natasha, Xavier, Dylan, Hains, Peter G., Bucio-Noble, Daniel, Aref, Adel T., Porceddu, Sandro V., Ladwa, Rahul, Whitfield, Joseph, Reddel, Roger R., Zhong, Qing, Panizza, Benedict J. and Robinson, Phillip J. (2025). A proteomic signature for human papillomavirus-associated oropharyngeal squamous cell carcinoma predicts patients at high risk of recurrence. Cancer Research Communications, 5 (4), 580-593. doi: 10.1158/2767-9764.crc-23-0460
Cox, Charlotte, Brown, Susan, Walpole, Euan, Roy, Edwige, Dousset, Lea, Ladwa, Rahul and Khosrotehrani, Kiarash (2025). Immune checkpoint inhibitors in field cancerization and keratinocyte cancer prevention. JAMA Dermatology, 161 (4), 383-390. doi: 10.1001/jamadermatol.2024.5750
Naei, Vahid Yaghoubi, Tubelleza, Rafael, Monkman, James, Sadeghirad, Habib, Donovan, Meg L., Blick, Tony, Wicher, Agata, Bodbin, Sara, Viratham, Amelie, Stad, Robert, Basu, Subham, Cooper, Caroline, Barnett, Catherine, O’Byrne, Ken, Ladwa, Rahul, Warkiani, Majid Ebrahimi, Hughes, Brett G. M. and Kulasinghe, Arutha (2025). Spatial interaction mapping of PD-1/PD-L1 in head and neck cancer reveals the role of macrophage-tumour barriers associated with immunotherapy response. Journal of Translational Medicine, 23 (1) 177, 1-15. doi: 10.1186/s12967-025-06186-y
Hughes, Brett G.M., Guminski, Alexander, Bowyer, Samantha, Migden, Michael R., Schmults, Chrysalyne D., Khushalani, Nikhil I., Chang, Anne Lynn S., Grob, Jean-Jacques, Lewis, Karl D., Ansstas, George, Day, Fiona, Ladwa, Rahul, Stein, Brian N., Muñoz Couselo, Eva, Meier, Friedegund, Hauschild, Axel, Schadendorf, Dirk, Basset-Seguin, Nicole, Modi, Badri, Dalac-Rat, Sophie, Dunn, Lara A., Flatz, Lukas, Mortier, Laurent, Guégan, Sarah, Heinzerling, Lucie M., Mehnert, Janice M., Trabelsi, Sabiha, Soria-Rivas, Ainara, Stratigos, Alexander J. ... Rischin, Danny (2025). A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of Groups 1, 2, and 3, and primary analysis of fixed-dose treatment Group 6. Journal of the American Academy of Dermatology, 92 (1), 68-77. doi: 10.1016/j.jaad.2024.06.108
Ladwa, Rahul and McGrath, Margaret (2025). Outcomes from early discontinuation of immune checkpoint inhibitor therapy following response in patients with advanced cutaneous squamous cell carcinoma. EJC Skin Cancer, 3 100759, 100759. doi: 10.1016/j.ejcskn.2025.100759
Huang, Xiaomin, Zhang, Xi, Weeramange, Chameera Ekanayake, Leo, Paul, Hughes, Brett G. M., Dolcetti, Riccardo, Zeng, Bijun, Mazzieri, Roberta, Hartel, Gunter, Ladwa, Rahul, Taheri, Touraj, Breik, Omar, Kenny, Lizbeth, Vasani, Sarju and Punyadeera, Chamindie (2025). Development of a circulating tumour cell culture model from head and neck squamous cell carcinoma. VIEW, 6 (6) 20250085. doi: 10.1002/VIW.20250085
Zhang, Xi, Weeramange, Chameera Ekanayake, Hughes, Brett G. M., Vasani, Sarju, Liu, Zhen Yu, Warkiani, Majid, Hartel, Gunter, Ladwa, Rahul, Thiery, Jean Paul, Kenny, Liz, Breik, Omar and Punyadeera, Chamindie (2024). Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma patients. Cellular and Molecular Life Sciences, 81 (1) 233, 1-14. doi: 10.1007/s00018-024-05269-1
Webb, Penelope M, Brown, Amy, Brown, Bena, Collins, Louisa G, Crawford Williams, Fiona, Doupain, Kerrie, Eastgate, Melissa, Fennelly, Vicki, Girgis, Afaf, Hartel, Gunter, Ladwa, Rahul, Martin, Karen, Mason, Robert, McGuire, Peter, Miller, Elizabeth, O’Brien, Suzanne, Packer, Rebecca, Pinkham, Mark B, Sabesan, Sabe, Sanmugarajah, Jasotha, Slapp, Georgia, Tapsall, Doreen, White, Jeanie, Wishart, Laurelie R, Wyld, David and Chan, Raymond J (2024). Patient Reported Outcome Measures in cancer care: a hybrid effectiveness-Implementation trial to optimise Symptom control and health service Experience (PROMISE)–protocol for a randomised controlled trial of electronic self-reporting of symptoms versus usual care during and following treatment in patients with cancer. BMJ Open, 14 (11) e090836, 1-10. doi: 10.1136/bmjopen-2024-090836
Fletcher, J., Reid, N., Hubbard, R.E., Berry, R., Weston, M., Walpole, E., Kimberley, R., Thaker, D.A. and Ladwa, R. (2024). Frailty index, not age, predicts treatment outcomes and adverse events for older adults with cancer. Journal of Frailty and Aging, 13 (4), 487-494. doi: 10.14283/jfa.2024.22
Lester, Georgia M., Wilson, Wayne J., Timmer, Barbra H. B. and Ladwa, Rahul M. (2024). A retrospective audit of audiology encounters in patients undergoing Cisplatin treatment at a large Australian tertiary cancer care centre. Journal of Cancer Survivorship, 1-7. doi: 10.1007/s11764-024-01689-x
Berrell, Naomi, Monkman, James, Donovan, Meg, Blick, Tony, O'Byrne, Ken, Ladwa, Rahul, Tan, Chin Wee and Kulasinghe, Arutha (2024). Spatial resolution of the head and neck cancer tumor microenvironment to identify tumor and stromal features associated with therapy response. Immunology and Cell Biology, 102 (9), 830-846. doi: 10.1111/imcb.12811
Sadeghirad, Habib, Monkman, James, Tan, Chin Wee, Liu, Ning, Yunis, Joseph, Donovan, Meg L., Moradi, Afshin, Jhaveri, Niyati, Perry, Chris, Adams, Mark N., O’Byrne, Ken, Warkiani, Majid E., Ladwa, Rahul, Hughes, Brett G.M. and Kulasinghe, Arutha (2024). Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response. Journal of Translational Medicine, 22 (1) 677, 677. doi: 10.1186/s12967-024-05409-y
Ladwa, Rahul, Fogarty, Gerald, Chen, Peggy, Grewal, Gurpreet, McCormack, Chris, Mar, Victoria, Kerob, Delphine and Khosrotehrani, Kiarash (2024). Management of skin toxicities in cancer treatment: an Australian/New Zealand perspective. Cancers, 16 (14) 2526, 1-16. doi: 10.3390/cancers16142526
Ladwa, Rahul, Chandra, Janin, Woo, Wai-Ping, Finlayson, Neil, Liu, Howard, McGrath, Margaret, See, Adrienne, Hughes, Brett G., Cooper, Caroline L., Jackson, Jim E., Dzienis, Marcin, Xu, Yan, Panizza, Benedict, Frazer, Ian and Porceddu, Sandro V. (2024). A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma. Frontiers in Oncology, 14 1419258, 1-8. doi: 10.3389/fonc.2024.1419258
Barnett, Catherine, Bowman, James, Ladwa, Rahul, McGrath, Margaret, Liu, Howard, Gandhi, Mitesh, Zahir, Syeda Farah, Porceddu, Sandro and Panizza, Benedict (2024). Long‐term outcomes in advanced anterior skull base malignancy: a single quaternary institution experience. ANZ Journal of Surgery, 94 (12), 2165-2172. doi: 10.1111/ans.19144
Yaghoubi Naei, Vahid, Ivanova, Ekaterina, Mullally, William, O'Leary, Connor G, Ladwa, Rahul, O'Byrne, Ken, Warkiani, Majid E and Kulasinghe, Arutha (2024). Characterisation of circulating tumor‐associated and immune cells in patients with advanced‐stage non‐small cell lung cancer. Clinical and Translational Immunology, 13 (6) e1516, e1516. doi: 10.1002/cti2.1516
Porceddu, Sandro, Negrello, Theresa, Rawson, Neal, Dunn, Nathan, Batstone, Martin, Collins, Michael, Dowthwaite, Sam, Hughes, Brett G. M., Kenny, Liz, Ladwa, Rahul, Panizza, Ben and Cossio, Danica (2024). Human papillomavirus associated oropharyngeal cancer now the most common mucosal head and neck cancer in Queensland. Journal of Medical Imaging and Radiation Oncology, 68 (4), 472-480. doi: 10.1111/1754-9485.13643
McLean, Luke S, Lim, Annette M, Bressel, Mathias, Lee, Jenny, Ladwa, Rahul, Guminski, Alexander D, Hughes, Brett, Bowyer, Samantha, Briscoe, Karen, Harris, Samuel, Kukard, Craig, Zielinski, Rob, Alamgeer, Muhammad, Carlino, Matteo, Mo, Jeremy, Park, John J, Khattak, Muhammad A, Day, Fiona and Rischin, Danny (2024). Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study. Medical Journal of Australia, 220 (2), 80-90. doi: 10.5694/mja2.52199
Ekanayake Weeramange, Chameera, Tang, Kai Dun, Irwin, Darryl, Hartel, Gunter, Langton-Lockton, Julian, Ladwa, Rahul, Kenny, Lizbeth, Taheri, Touraj, Whitfield, Bernard, Vasani, Sarju and Punyadeera, Chamindie (2024). Human papillomavirus (HPV) DNA methylation changes in HPV-associated head and neck cancer. Carcinogenesis, 45 (3), 140-148. doi: 10.1093/carcin/bgae001
Arnfield, Evyn G., Tam, Laura, Pattison, David A., Younger, John, Chikatamarla, Venkata Avinash, Wyld, David, Burge, Matthew, McCormack, Louise, Ladwa, Rahul and Ramsay, Stuart (2023). Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI. Journal of Nuclear Cardiology, 30 (6), 2676-2691. doi: 10.1007/s12350-023-03345-w
Lester, Georgia M., Wilson, Wayne J., Timmer, Barbra H. B. and Ladwa, Rahul M. (2023). Audiological ototoxicity monitoring guidelines: a review of current evidence and appraisal of quality using the AGREE II tool. International Journal of Audiology, 63 (10), 1-6. doi: 10.1080/14992027.2023.2278018
Gupta, Ruta, Selinger, Christina I., Ashford, Bruce, Chua, Margaret S.T., Clark, Jonathan R., Damian, Diona L., Jackett, Louise A., James, Craig, Johnson, Stuart, Ladwa, Rahul, Lambie, Duncan, McKenzie, Catriona, Tan, Swee T. and Scolyer, Richard A. (2023). Implementing structured pathology reporting protocol for non-melanocytic skin cancers: practical considerations. Pathology, 55 (6), 743-759. doi: 10.1016/j.pathol.2023.07.003
Clingan, Philip, Ladwa, Rahul, Brungs, Daniel, Harris, Dean Laurence, McGrath, Margaret, Arnold, Susan, Coward, Jermaine, Fourie, Samuel, Kurochkin, Andriy, Malan, Daniel R., Mant, Andrew, Sharma, Vinay, Shue, Hong, Tazbirkova, Andrea, Berciano-Guerrero, Miguel-Angel, Charoentum, Chaiyut, Dalle, Stéphane, Dechaphunkul, Arunee, Dudnichenko, Oleksandr, Koralewski, Piotr, Lugowska, Iwona, Montaudié, Henri, Muñoz-Couselo, Eva, Sriuranpong, Virote, Oliviero, James and Desai, Jayesh (2023). Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma. Journal for ImmunoTherapy of Cancer, 11 (10) e007637, e007637. doi: 10.1136/jitc-2023-007637
Causer, Andrew, Tan, Xiao, Lu, Xuehan, Moseley, Philip, Teoh, Siok M., Molotkov, Natalie, McGrath, Margaret, Kim, Taehyun, Simpson, Peter T., Perry, Christopher, Frazer, Ian H., Panizza, Benedict, Ladwa, Rahul, Nguyen, Quan and Gonzalez-Cruz, Jazmina L. (2023). Deep spatial-omics analysis of Head & Neck carcinomas provides alternative therapeutic targets and rationale for treatment failure. n p j Precision Oncology, 7 (1) 89, 1-13. doi: 10.1038/s41698-023-00444-2
Monkman, James, Kim, Honesty, Mayer, Aaron, Mehdi, Ahmed, Matigian, Nicholas, Cumberbatch, Marie, Bhagat, Milan, Ladwa, Rahul, Mueller, Scott N., Adams, Mark N., O'Byrne, Ken and Kulasinghe, Arutha (2023). Multi‐omic and spatial dissection of immunotherapy response groups in non‐small cell lung cancer. Immunology, 169 (4), 487-502. doi: 10.1111/imm.13646
Gupta, Ruta, Bal, Munita, Bishop, Justin A., Hunter, Keith D., Magliocca, Kelly, Seethala, Raja R., Thompson, Lester D. R., Weinreb, Ilan, Angelos, Peter, Beadle, Beth, Bell, R. Bryan, Clark, Jonathan R., Ferris, Robert, Huang, Shao Hui, Hayes, D. Neil, Ladwa, Rahul, Yang, Jean, Cipriani, Nicole A., Nelson, Brenda L., Sadow, Peter M. and Lewis, James S. (2023). HN-CLEAR: head and neck consensus language for ease and reproducibility, a multidisciplinary consensus mechanism for head and neck pathology. Head and Neck Pathology, 17 (3), 877-880. doi: 10.1007/s12105-023-01570-w
Ekanayake Weeramange, Chameera, Tang, Kai Dun, Barrero, Roberto A., Hartel, Gunter, Liu, Zhen, Ladwa, Rahul, Langton-Lockton, Julian, Frazer, Ian, Kenny, Lizbeth, Vasani, Sarju and Punyadeera, Chamindie (2023). Salivary micro RNAs as biomarkers for oropharyngeal cancer. Cancer Medicine, 12 (14), 15128-15140. doi: 10.1002/cam4.6185
Fletcher, James A., Logan, Benignus, Reid, Natasha, Gordon, Emily H., Ladwa, Rahul and Hubbard, Ruth E. (2023). How frail is frail in oncology studies? A scoping review. BMC Cancer, 23 (1) 498, 498. doi: 10.1186/s12885-023-10933-z
Sadeghirad, Habib, Liu, Ning, Monkman, James, Ma, Ning, Cheikh, Bassem Ben, Jhaveri, Niyati, Tan, Chin Wee, Warkiani, Majid Ebrahimi, Adams, Mark N., Nguyen, Quan, Ladwa, Rahul, Braubach, Oliver, O’Byrne, Ken, Davis, Melissa, Hughes, Brett G. M. and Kulasinghe, Arutha (2023). Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy. Frontiers in Immunology, 14 1135489, 1-16. doi: 10.3389/fimmu.2023.1135489
Itchins, Malinda, Ainsworth, Hannah, Alexander, Marliese, Dean, Samantha, Dharmaraj, Devi, Pavlakis, Nick, Clarke, Stephen J., Brown, Chris, Torres, Javier, Saqib, Ayesha, Ladwa, Rahul, O'Byrne, Kenneth, Moore, Melissa, Yip, Po Yee, Solomon, Ben, John, Tom, Kao, Steven, Mitchell, Paul and Parakh, Sagun (2022). A multi-center real-world experience of IMpower150 in oncogene driven tumors and CNS metastases. Clinical Lung Cancer, 23 (8), 702-708. doi: 10.1016/j.cllc.2022.07.016
Fletcher, James, Fox, Sarah, Reid, Natasha, Hubbard, Ruth E. and Ladwa, Rahul (2022). The impact of frailty on health outcomes in older adults with lung cancer: a systematic review. Cancer Treatment and Research Communications, 33 100652, 1-10. doi: 10.1016/j.ctarc.2022.100652
Kapeleris, Joanna, Bark, Juliana Müller, Ranjit, Shanon, Irwin, Darryl, Hartel, Gunter, Warkiani, Majid Ebrahimi, Leo, Paul, O’Leary, Connor, Ladwa, Rahul, O'Byrne, Kenneth, Hughes, Brett G.M. and Punyadeera, Chamindie (2022). Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer. Heliyon, 8 (7) e09971, 1-9. doi: 10.1016/j.heliyon.2022.e09971
Zhang, Xi, Ekanayake Weeramange, Chameera, Hughes, Brett G. M., Vasani, Sarju, Liu, Zhen Yu, Warkiani, Majid Ebrahimi, Hartel, Gunter, Ladwa, Rahul, Thiery, Jean Paul, Kenny, Liz and Punyadeera, Chamindie (2022). Application of circulating tumour cells to predict response to treatment in head and neck cancer. Cellular Oncology, 45 (4), 1-13. doi: 10.1007/s13402-022-00681-w
Sadeghirad, Habib, Monkman, James, Mehdi, Ahmed M., Ladwa, Rahul, O’Byrne, Ken, Hughes, Brett G. M. and Kulasinghe, Arutha (2022). Dissecting Tissue Compartment-Specific Protein Signatures in Primary and Metastatic Oropharyngeal Squamous Cell Carcinomas. Frontiers in Immunology, 13 895513, 1-11. doi: 10.3389/fimmu.2022.895513
Ladwa, Rahul, Pinkham, Elizabeth P., Teleni, Laisa, Hanley, Brigid, Lock, Gemma, Nixon, Jodie, Agbejule, Oluwaseyifunmi Andi, Crawford-Williams, Fiona, Jones, Lee, Pinkham, Mark B., Turner, Jane, Yates, Patsy, McPhail, Steven M., Aitken, Joanne F., Escalante, Carmen P., Hart, Nicolas H. and Chan, Raymond J. (2022). Telehealth cancer-related fatigue clinic model for cancer survivors: a pilot randomised controlled trial protocol (the T-CRF trial). BMJ Open, 12 (5) e059952, 1-13. doi: 10.1136/bmjopen-2021-059952
Nightingale, James, Gandhi, Mitesh, Helena, Jonathan, Bowman, James, McGrath, Margaret, Coward, Jermaine, Porceddu, Sandro, Ladwa, Rahul and Panizza, Benedict (2022). Immunotherapy for the treatment of perineural spread in cutaneous head and neck squamous cell carcinoma: time to rethink treatment paradigms. Head and Neck, 44 (5), 1099-1105. doi: 10.1002/hed.27005
Shiravand, Yavar, Khodadadi, Faezeh, Kashani, Seyyed Mohammad Amin, Hosseini-Fard, Seyed Reza, Hosseini, Shadi, Sadeghirad, Habib, Ladwa, Rahul, O’Byrne, Ken and Kulasinghe, Arutha (2022). Immune checkpoint inhibitors in cancer therapy. Current Oncology, 29 (5), 3044-3060. doi: 10.3390/curroncol29050247
Kapeleris, Joanna, Ebrahimi Warkiani, Majid, Kulasinghe, Arutha, Vela, Ian, Kenny, Liz, Ladwa, Rahul, O’Byrne, Kenneth and Punyadeera, Chamindie (2022). Clinical applications of circulating tumour cells and circulating tumour dna in non-small cell lung cancer—an update. Frontiers in Oncology, 12 859152, 1-18. doi: 10.3389/fonc.2022.859152
Ekanayake Weeramange, Chameera, Shu, Danhua, Tang, Kai Dun, Batra, Jyotsna, Ladwa, Rahul, Kenny, Lizbeth, Vasani, Sarju, Frazer, Ian H., Dolcetti, Riccardo, Ellis, Jonathan J., Sturm, Richard A., Leo, Paul and Punyadeera, Chamindie (2022). Analysis of human leukocyte antigen associations in human papillomavirus–positive and –negative head and neck cancer: Comparison with cervical cancer. Cancer, 128 (10), 1937-1947. doi: 10.1002/cncr.34148
Herath, Sayuri, Sadeghi Rad, Habib, Radfar, Payar, Ladwa, Rahul, Warkiani, Majid, O’Byrne, Ken and Kulasinghe, Arutha (2022). The role of circulating biomarkers in lung cancer. Frontiers in Oncology, 11 801269, 1-13. doi: 10.3389/fonc.2021.801269
Rad, Habib Sadeghi, Shiravand, Yavar, Radfar, Payar, Ladwa, Rahul, Perry, Chris, Han, Xiaoyuan, Warkiani, Majid Ebrahimi, Adams, Mark N., Hughes, Brett G.M., O'Byrne, Ken and Kulasinghe, Arutha (2022). Understanding the tumor microenvironment in head and neck squamous cell carcinoma. Clinical & Translational Immunology, 11 (6) e1397, e1397. doi: 10.1002/cti2.1397
Agbejule, Oluwaseyifunmi Andi, Hart, Nicolas H., Ekberg, Stuart, Bogda, Koczwara, Ladwa, Rahul, Simonsen, Camilla, Pinkham, Elizabeth P. and Chan, Raymond Javan (2021). Bridging the research to practice gap: a systematic scoping review of implementation of interventions for cancer-related fatigue management. BMC Cancer, 21 (1) 809, 882. doi: 10.1186/s12885-021-08394-3
Kulasinghe, Arutha, O'Leary, Connor, Monkman, James, Bharti, Vandhana, Irwin, Darryl, Dutta, Sanjay, Richard, Derek J., Hughes, Brett, Ladwa, Rahul and O'Byrne, Ken (2021). The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC). Lung Cancer, 160, 73-77. doi: 10.1016/j.lungcan.2021.08.005
Tay, Ban Qi, Wright, Quentin, Ladwa, Rahul, Perry, Christopher, Leggatt, Graham, Simpson, Fiona, Wells, James W., Panizza, Benedict J., Frazer, Ian H. and Cruz, Jazmina L. G. (2021). Evolution of cancer vaccines—challenges, achievements and future directions. Vaccines, 9 (5) 535, 535. doi: 10.3390/vaccines9050535
Sadeghi Rad, Habib, Monkman, James, Warkiani, Majid E., Ladwa, Rahul, O'Byrne, Ken, Rezaei, Nima and Kulasinghe, Arutha (2021). Understanding the tumor microenvironment for effective immunotherapy. Medicinal Research Reviews, 41 (3), 1474-1498. doi: 10.1002/med.21765
Liu, Howard Yu-hao, Daniels, Christopher P., Trada, Yuvnik, Bernard, Anne, You, Kyung Ha, Brown, Elizabeth, Foote, Matthew, McGrath, Margaret, Ladwa, Rahul, Panizza, Benedict James and Porceddu, Sandro Virgilio (2021). The importance of smoking status at diagnosis in human papillomavirus-associated oropharyngeal cancer. Head and Neck, 43 (5), 1440-1450. doi: 10.1002/hed.26612
Chan, David L., Ulaner, Gary A., Pattison, David A., Wyld, David, Ladwa, Rahul, Kirchner, Julian, Li, Bob T, Lai, W Victoria, Pavlakis, Nick, Roach, Paul J and Bailey, Dale L (2021). Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): the NETPET score as a prognostic biomarker. Journal of Nuclear Medicine, 62 (9), 1278-1284. doi: 10.2967/jnumed.120.257659
Nightingale, James, Lum, Benedict, Ladwa, Rahul, Simpson, Fiona and Panizza, Benedict (2021). Adenoid cystic carcinoma: a review of clinical features, treatment targets and advancement in improving the immune response to monoclonal antibody therapy. Biochimica et Biophysica Acta. Reviews on Cancer, 1875 (2) 188523, 1-9. doi: 10.1016/j.bbcan.2021.188523
Monkman, James, Taheri, Touraj, Warkiani, Majid Ebrahimi, O’Leary, Connor, Ladwa, Rahul, Richard, Derek, O’ Byrne, Ken and Kulasinghe, Arutha (2020). High-plex and high-throughput digital spatial profiling of non-small-cell lung cancer (NSCLC). Cancers, 12 (12) 3551, 1-16. doi: 10.3390/cancers12123551
Kulasinghe, Arutha, Monkman, James, Nalder, Mark, O’Leary, Connor, Ladwa, Rahul and O’Byrne, Ken (2020). Transformation or progression from adenocarcinoma to small cell lung cancer detected by serially tracking mutations in the blood. Reports, 3 (4) 33, 33. doi: 10.3390/reports3040033
Daniels, Christopher P., Liu, Howard Yu-hao, Bernard, Anne, Williams, Christopher, Foote, Matthew C., Ladwa, Rahul, McGrath, Margaret, Panizza, Benedict James and Porceddu, Sandro Virgilio (2020). The declining role of post-treatment neck dissection in human papillomavirus-associated oropharyngeal cancer. Radiotherapy and Oncology, 151, 242-248. doi: 10.1016/j.radonc.2020.08.004
Chandra, J., Woo, W. P., Finlayson, N., Liu, H. Y., McGrath, M., Ladwa, R., Brauer, M., Xu, Y., Hanson, S., Panizza, B., Frazer, I. H. and Porceddu, Sandro V. (2020). A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC). Cancer Immunology, Immunotherapy, 70 (3), 743-753. doi: 10.1007/s00262-020-02720-7
Ladwa, Rahul, Roberts, Kate E., O'Leary, Connor, Maggacis, Nicole, O'Byrne, Kenneth J. and Miles, Kenneth (2020). Computed tomography texture analysis of response to second-line nivolumab in metastatic non-small cell lung cancer. Lung Cancer Management, 9 (3) LMT38, 1-8. doi: 10.2217/lmt-2020-0002
Masterson, Liam, Howard, James, Gonzalez-Cruz, Jazmina, Jackson, Christopher, Barnett, Catherine, Overton, Lewis, Liu, Howard, Ladwa, Rahul, Simpson, Fiona, McGrath, Margie, Wallwork, Ben, Jones, Terry, Ottensmeier, Christian, Chua, Melvin L. K., Perry, Chris, Khanna, Rajiv, Panizza, Benedict, Porceddu, Sandro and Lechner, Matt (2020). Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?. International Journal of Cancer, 146 (8) ijc.32869, 2305-2314. doi: 10.1002/ijc.32869
Tani, Daniel, Ladwa, Rahul, Xu, Wen, Lwin, Zarnie, Steinke, Karin and Hughes, Brett G. M. (2020). Outcomes of incidental pulmonary nodules in head-and-neck squamous cell cancer patients treated with curative intent. Journal of Head and Neck Physicians and Surgeons, 8 (1), 17-22. doi: 10.4103/jhnps.jhnps_39_19
O'Leary, Connor Gerard, Andelkovic, Vladamir, Ladwa, Rahul, Pavlakis, Nick, Zhou, Caicun, Hirsch, Fred, Richard, Derek and O'Byrne, Kenneth (2019). Targeting BRAF mutations in non-small cell lung cancer. Translational Lung Cancer Research, 8 (6), 1119-1124. doi: 10.21037/tlcr.2019.10.22
Ladwa, Rahul and Atkinson, Victoria (2018). The changing paradigm of management in melanoma brain metastases. Asia Pacific Journal of Clinical Oncology, 14 (6), 453-458. doi: 10.1111/ajco.12998
Ladwa, Rahul, Kalas, Timothy, Pathmanathan, Shivanshan, Woodward, Natasha, Wyld, David and Sanmugarajah, Jasotha (2018). Maintaining dose intensity of adjuvant chemotherapy in older patients with breast cancer. Clinical Breast Cancer, 18 (5), e1181-e1187. doi: 10.1016/j.clbc.2018.04.016
Ladwa, Rahul, Wen Hong, Hooi, Wyld, David, Pattison, David A. and Burge, Matthew (2018). Tumor cystic necrosis following peptide receptor radionuclide therapy in neuroendocrine tumors. Clinical Nuclear Medicine, 43 (3), 186-187. doi: 10.1097/RLU.0000000000001970
Ladwa, Rahul, Gustafson, Sonja, McCaffrey, Elizabeth, Miles, Kenneth and O'Byrne, Kenneth (2017). A rare case of omentum invasive prostate cancer: staging With PSMA PET/CT imaging and response to systemic therapy. Clinical Nuclear Medicine, 42 (6), e311-e312. doi: 10.1097/RLU.0000000000001619
Ladwa, Rahul and Atkinson, Victoria (2017). The cessation of anti-PD-1 antibodies of complete responders in metastatic melanoma. Melanoma Research, 27 (2), 168-170. doi: 10.1097/CMR.0000000000000336
Ladwa, Rahul and Sanmugarajah, Jasotha (2016). The feasibility and tolerability of newer chemotherapy regimens in the adjuvant setting in older patients with breast cancer. Breast Journal, 22 (2), 244-246. doi: 10.1111/tbj.12559
Goh, Jeffrey, Mohan, G. Raj, Ladwa, Rahul, Ananda, Sumitra, Cohen, Paul A. and Baron-Hay, Sally (2015). Frontline treatment of epithelial ovarian cancer. Asia-Pacific Journal of Clinical Oncology, 11 (Supplement s6), 1-16. doi: 10.1111/ajco.12449
Ladwa, Rahul, Peters, Geoffrey, Bigby, Kieron and Chern, Boris (2015). Posterior Reversible Encephalopathy Syndrome in Early-Stage Breast Cancer. Breast Journal, 21 (6), 674-677. doi: 10.1111/tbj.12502
Conference Papers
Ladwa, R., Hughes, B.G.M., Panizza, B., Cooper, C., Liu, H., Bowman, J., Gupta, R., Cuscaden, C., Nottage, M.K., Clarke, J., McGrath, M., Porceddu, S.V. and Lee, J. (2025). De-squamate study: Event-free survival outcomes in clinical or pathological complete responders. ESMO Congress 2025, Berlin, Germany, 17-21 October 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2025.08.2285
Rischin, D., Porceddu, S., Day, F., Brungs, D., Christie, H., Jackson, J.E., Stein, B., Su, Y.B., Ladwa, R., Adams, G., Bowyer, S.E., Otty, Z., Bossi, P., Challapalli, A., Hauschild, A., Lim, A.M.L., Seebach, F.A., Yoo, S-Y., Goncalves, P. and Fury, M. (2025). Analysis of second primary cutaneous squamous cell carcinoma (CSCC) tumors (SPTs) reported during the C-POST trial, a randomized phase III study of adjuvant cemiplimab vs placebo (pbo) for high-risk CSCC. ESMO Congress 2025, Berlin, Germany, 17-21 October 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2025.08.2231
Rischin, D., Porceddu, S., Day, F., Christie, H., Jackson, J.E., Stein, B., Su, Y.B., Ladwa, R., Yamazaki, N., Bossi, P., Challapalli, A., Hauschild, A., Seebach, F.A., Cardozo, F., Yoo, S-Y., Ju, H., Bansal, S., Goncalves, P., Fury, M. and Visich, J. (2025). Adjuvant cemiplimab for high-risk cutaneous squamous cell carcinoma: Evaluating dosing intervals in a phase III trial. ESMO Congress 2025, Berlin, Germany, 17-21 October 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2025.08.2288
McGrath, M. and Ladwa, R. (2025). Outcomes from discontinuation of immune checkpoint inhibitors (ICI) following response in patients with advanced cutaneous squamous cell carcinoma (cSCC). ESMO Congress 2025, Berlin, Germany, 17-21 October 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2025.08.1986
Thavaneswaran, S., Espinoza, D., Lin, F.P., Chinchen, S., Kansara, M., Ballinger, M., Grady, J., Grimison, P., Millward, M., Ladwa, R., Joshua, A.M., Desai, J., Simes, J. and Thomas, D. (2025). Phase II trial of Vismodegib in advanced cancers with Hedgehog pathway alterations. ESMO Congress 2025, Berlin, Germany, 17-21 October 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2025.08.1542
Rischin, Danny, Porceddu, Sandro V., Day, Fiona, Brungs, Daniel, Christie, Hayden Robert, Jackson, James Estes, Stein, Brian N., Su, Yungpo, Adams, Gerard, Bowyer, Samantha, Otty, Zulfiquer Ali, Yamazaki, Naoya, Bossi, Paolo, Challapalli, Amarnath, Ladwa, Rahul, Hauschild, Axel, Seebach, Frank A., Yoo, Suk-Young, Goncalves, Priscila Hermont and Fury, Matthew G. (2025). Phase 3 trial of adjuvant cemiplimab (cemi) versus placebo (pbo) for high-risk cutaneous squamous cell carcinoma (CSCC). 2025 ASCO Annual Meeting, Chicago, IL United States, 30 May - 3 June 2025. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2025.43.16_suppl.6001
Tan, Chin Wee, Berrell, Naomi, Donovan, Meg L., Monkman, James, Sadeghirad, Habib, Naei, Vahid Yaghoubi, Chen, Jinjin, Rossenbloom, Alyssa, Bonnett, Shilah, Conner, Mark, Filanoski, Brian, Kang, Christine, Beechem, Joseph M., Fraser, John F., Barnett, Catherine, Ladwa, Rahul, Hughes, Brett G. and Kulasinghe, Arutha (2025). Characterising head and neck tumour microenvironment using high plex spatial omics technologies and analyses. AACR Annual Meeting 2025, Chicago, IL United States, 25-30 April 2025. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2025-175
Naei, Vahid Yaghoubi, Tubelleza, Rafael, Monkman, James, Sadeghirad, Habib, Donovan, Meg L., Blick, Tony, Wicher, Agata, Bodbin, Sara, Basu, Subham, Stad, Robert, Barnett, Catherine, O’Byrne, Ken, Ladwa, Rahul, Cooper, Caroline, Warkiani, Majid Ebrahimi, Hughes, Brett G.M. and Kulasinghe, Arutha (2025). Exploring PD1/PDL1 interactions and macrophage-tumor barriers in head and neck cancer: A spatial approach to immunotherapy response. AACR Annual Meeting 2025, Chicago, IL United States, 25-30 April 2025. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2025-750
Donovan, Meg L., Sadeghirad, Habib, Berrell, Naomi, Monkman, James, Naei, Vahid Yaghoubi, Tan, Chin Wee, Yunis, Joseph, West, Zoe, Warkiani, Majid E., Ladwa, Rahul, Hughes, Brett G., Da Gama Duarte, Jessica and Kulasinghe, Arutha (2025). 2D and 3D spatial characterisation of tertiary lymphoid structures in head and neck cancer patients receiving immune checkpoint blockade therapy. AACR Annual Meeting 2025, Chicago, IL United States, 25-30 April 2025. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2025-5252
Silk, Ann W., Davar, Diwakar, Ladwa, Rahul, Lee, Jenny, Schadendorf, Dirk, Caglevic, Christian, Rey, Felipe, Yanez, Patricio, Meehan, Robert S., Posadas, Tracey, Wang, Anran, Yuan, Jianda, Gross, Neil and Koyfman, Shlomo (2024). Adaptive phase 2/3 randomized study of neoadjuvant and adjuvant pembrolizumab with V940 (mRNA-4157) for resectable locally advanced cutaneous squamous cell carcinoma: INTerpath-007. SITC 39th Annual Meeting (SITC 2024), Houston, TX United States, 6-10 November 2024. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2024-sitc2024.0652
Ladwa, R., Davar, D., Lee, J., Silk, A.W., Popovtzer, A., Asher, N., Khattak, M.A., Meehan, R., Posadas, T., Wang, A., Yuan, J., Gross, N., Koyfman, S. and Schadendorf, D. (2024). INTerpath-007: A phase II/III, adaptive, randomized study of neoadjuvant and adjuvant pembrolizumab (pembro) with V940 (mRNA-4157) for treatment of resectable locally advanced (LA) cutaneous squamous cell carcinoma (cSCC). ESMO Congress 2024, Barcelona, Spain, 13-17 September 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2024.08.1001
Muñoz-Couselo, E., Montaudie, H., Berciano Guerrero, M.A., Alamo De La Gala, M.D.C., Charles, J., Quereux, G., Nardin, C., Tur, R. Yaya, Dalle, S., Beylot-Barry, M., Ladwa, R., McGrath, M., Brungs, D., Harris, D., Shue, H., Tazbirkova, A., Fourie, S.J., Malan, D.R., Oliviero, J. and Clingan, P. (2024). Cosibelimab in advanced cutaneous squamous cell carcinoma (CSCC): Longer-term efficacy and safety results from pivotal study. ESMO Congress 2024, Barcelona, Spain, 13-17 September 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2024.08.2139
Panizza, Benedict J., O'Leary, Stephen John, Hart, Christopher David, Diwakarla, Chandra Sai, Barnett, Catherine, Lapuerta, Pablo, Lee, John, Raines, Shane, Quigley, Tera, Wolff, Heather M., Keilty, John, Ladwa, Rahul, Porceddu, Sandro V., McGrath, Margaret, Seetharamu, Nagashree, Fua, Tsien and Rischin, Danny (2024). A phase 1 clinical trial of DB-020 intratympanic injections administered prior to high-dose cisplatin chemotherapy to reduce ototoxicity. 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2024.42.16_suppl.6100
Ladwa, Rahul, Lee, Jenny H.J., Porceddu, Sandro V., McGrath, Margaret Louise, Cooper, Caroline, Liu, Howard, Gupta, Ruta, Cuscaden, Claire, Nottage, Michelle K., Clark, Jonathan, Le, Dieu, Pauley, Marketa, Gonzalez-Cruz, Jazmina, Frazer, Ian, Hughes, Brett Gordon Maxwell and Panizza, Benedict J. (2024). A phase 2 study of de-escalation in resectable, locally advanced cutaneous squamous cell carcinoma (cSCC) with the use of neoadjuvant pembrolizumab: De-Squamate. 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2024.42.16_suppl.9514
Ladwa, Rahul, Kenyon, Sarrinder, Jagger, Gillian, McGrath, Margaret Louise and Cuscaden, Claire (2024). Using serial 18F-FDG PET/CT PERCIST response to predict responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma. 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2024.42.16_suppl.9548
Hardy, Janet Rea, Greer, Ristan, Gurgenci, Taylan, Kearney, Alison, Ladwa, Rahul, Huggett, Georgie and Good, Phillip (2024). A randomized, double-blind controlled trial of medicinal cannabis vs placebo for symptom management in patients with advanced cancer receiving palliative care. 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2024.42.16_suppl.12020
Koyfman, S.A., Silk, A.W., Davar, D., Schadendorf, D., Clark, J.R., Ladwa, R., Lee, J., Suttner, L.H., Groisberg, R., Jin, F. and Hanna, G.J. (2024). A Randomized, Double-Blind, Phase 2 Study of Perioperative MK-4280A (Coformulation of Favezelimab and Pembrolizumab) vs Pembrolizumab in Patients with Resectable Cutaneous Squamous Cell Carcinoma (cSCC). 2024 Multidisciplinary Head and Neck Cancers Symposium, Phoenix, AZ United States, 29 February - 2 March 2024). Philadelphia, PA United States: Elsevier. doi: 10.1016/j.ijrobp.2024.01.191
Sadeghirad, Habib, Naei, Vahid Yaghoubi, Monkman, James, Basu, Subham, Wicher, Agata, Ladwa, Rahul, Hughes, Brett G.M. and Kulasinghe, Arutha (2024). Defining PD-1/PD-L1 receptor-ligand interactions in the head and neck cancer tumor microenvironment identifies unique ‘immune cell rivers’ of cellular interactions. American Association for Cancer Research Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-5188
Bhatia, S., Davar, D., Thomas, S., Silk, A.W., Wu, R.C., Ladwa, R., Park, S.J., Kelly, C.M., Wong, D.J., Grewal, J., Vohra, N., Lim, A.M., Puegero, J., Verschraegen, C., Zhong, B., Lowy, I., Fury, M. and Cristea, M. (2024). Phase 2 study of intratumoral vidutolimod in combination with intravenous cemiplimab in patients with selected advanced cancer or metastatic cancer: trial in progress. 20th EADO Congress 2024, Paris, France, 4-6 April 2024. London, United Kingdom: Elsevier. doi: 10.1016/j.ejcskn.2024.100240
Schadendorf, D., Koyfman, S., Silk, A.W., Davar, D., Clark, J., Ladwa, R., Lee, J., Suttner, L.H., Groisberg, R., Jin, F. and Hanna, G. (2024). A Randomized, Double-Blind, Phase 2 Study of Perioperative MK-4280A (Coformulation of Favezelimab and Pembrolizumab) vs Pembrolizumab in Patients With Resectable Cutaneous Squamous Cell Carcinoma. 20th EADO Congress 2024, Paris, France, 4-6 April 2024. London, United Kingdom: Elsevier. doi: 10.1016/j.ejcskn.2024.100214
Fletcher, J., Mullally, W.J., Berman, C., Ladwa, R., Xu, W. and O'Byrne, K. (2023). Real World Experience of First Line Pembrolizumab for Non-Small Cell Lung Cancer (NSCLC) at a Tertiary Centre. 2023 World Conference on Lung Cancer, Singapore, 9-12 September 2023. New York, NY United States: Elsevier. doi: 10.1016/j.jtho.2023.09.1192
Fletcher, J., Pringle, N., Mullally, W., O'Byrne, K., Xu, W. and Ladwa, R. (2023). Real World Chemoradiotherapy Outcomes for Frail Older Adults with Unresectable Stage III Non Small Cell Lung Cancer (NSCLC). 2023 World Conference on Lung Cancer, Singapore, 9-12 September 2023. New York, NY United States: Elsevier. doi: 10.1016/j.jtho.2023.09.1066
Ladwa, R., Monkman, J., Sadeghirad, H., Cooper, C., Belz, G., Bowman, J., Schaider, H., Liu, H., Kulasinghe, A. and Porceddu, S. (2023). High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study. ESMO Congress 2023, Madrid, Spain, 20-24 October 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2023.09.2278
Liu, Jia (Jenny), Jackson, Christopher, Anees, Asim, Noor, Zainab, Williams, Steven, Porceddu, Sandro, Liu, Howard, Ladwa, Rahul, Whitfield, Joseph, Reddel, Roger R., Zhong, Qing, Panizza, Benedict J. and Robinson, Phillip J (2023). A proteomic signature associated with prognosis in HPV-related locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC). 2023 ASCO Annual Meeting, Chicago, IL United States, 2-6 June 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.16_suppl.6055
Hughes, Brett, Grob, Jean-Jacques, Bowyer, Samantha, Day, Fiona, Ladwa, Rahul, Stein, Brian, Muñoz-Couselo, Eva, Basset-Seguin, Nicole, Guminski, Alexander, Mortier, Laurent, Hauschild, Axel, Migden, Michael, Schmults, Chrysalyne, Yoo, Suk-Young, Booth, Jocelyn, Seebach, Frank, Lowy, Israel, Fury, Matthew and Rischin, Danny (2023). Phase 2 confirmatory study of cemiplimab (350 mg IV Q3W) in patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Study 1540 Group 6. WCH23 Dermatology Conference, Kohala Coast, HI United States, 13-18 January 2023. Millwood, NY United States: National Society for Cutaneous Medicine. doi: 10.25251/skin.7.supp.175
Kulasinghe, Arutha, Monkman, James, Kim, Honesty, Mayer, Aaron, Mehdi, Ahmed, Cumberbatch, Marie, Bhagat, Milan, Schneider, Fabian, Thaagard, Jeppe, Mansfield, James, Ladwa, Rahul, Mueller, Scott, Adams, Mark and O’byrne, Kenneth (2022). Delineation of spatial tissue signatures of immunotherapy response groups in non-small cell lung cancer (NSCLC). SITC 37th Annual Meeting (SITC 2022), Boston, MA USA, 8-12 November 2022. London, United Kingdom: BMJ Publishing Group. doi: 10.1136/jitc-2022-sitc2022.0118
Kulasinghe, Arutha, Jhaveri, Niyati, Klymyshyn, Dmytro, Cheikh, Bassem Ben, Ladwa, Rahul, Liu, Howard, Cooper, Caroline, Belz, Gabrielle, Porceddu, Sandro and Braubach, Oliver (2022). High-dimensional spatial phenotyping of cutaneous squamous cell carcinoma from immune-competent and immunocompromised patients. SITC 37th Annual Meeting (SITC 2022), Boston, MA United States, 8–12 November 2022. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2022-sitc2022.0079
Kulasinghe, Arutha, Monkman, James, Kim, Honesty, Mayer, Aaron, Mehdi, Ahmed, Matigian, Nicholas, Cumberbatch, Marie, Bhagat, Milan, Ladwa, Rahul, Mueller, Scott, Adams, Mark and O'Byrne, Ken (2022). Multi-omic dissection of immunotherapy response groups in non-small cell lung cancer (NSCLC). AACR Annual Meeting 2022, New Orleans, LA United States, 8-13 April 2022. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2022-2036
Kulasinghe, Arutha, Monkman, James, Dutta, Sanjay, O’Leary, Connor, Ladwa, Rahul and O’Byrne, Ken (2021). The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC). 19th Annual British Thoracic Oncology Group Conference 2021, Virtual, 22-23 April 2021. Shannon, Ireland: Elsevier Ireland. doi: 10.1016/s0169-5002(21)00199-9
Dutta, Sanjay, Leo, Paul, Kulasinghe, Arutha, Monkman, James, Pennisi, David, Roberts, Kate, Ladwa, Rahul and O’Byrne, Ken (2021). Genetic mutations and signatures in lung cancer – findings from a whole exome sequencing platform. 19th Annual British Thoracic Oncology Group Conference 2021, Virtual, 22-23 April 2021. Shannon, Ireland: Elsevier Ireland. doi: 10.1016/s0169-5002(21)00200-2
Kulasinghe, Arutha, Monkman, James, Dutta, Sanjay, O'Leary, Connor, Ladwa, Rahul and O'Byrne, Ken (2021). The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC). 19th Annual British Thoracic Oncology Group Conference 2021, Virtual, 22-23 April 2021. Shannon, Ireland: Elsevier. doi: 10.1016/S0169-5002(21)00199-9
Nalder, Mark, Ladwa, Rahul, Raina, Anant, Burge, Matthew E., Love, Amanda, Pattison, David A., Ramsay, Stuart and Wyld, David (2021). 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with somatostatin-expressing neuroendocrine tumors: a real-world retrospective review of efficacy and safety from an Australian tertiary cancer Center. 2021 ASCO Annual Meeting I, Virtual, 4-8 June 2021. Alexandria, VA USA: American Society of Clinical Oncology. doi: 10.1200/jco.2021.39.15_suppl.e16198
Kulasinghe, Arutha, O’Leary, Connor, Ladwa, Rahul, Warkiani, Majid and O’byrne, Kenneth (2020). Highly multiplexed digital spatial profiling of the tumor microenvironment of non-small-cell lung cancer (NSCLC). 35th Anniversary Annual Meeting (SITC 2020), Virtual, 9-14 November 2020. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2020-sitc2020.0043
O'Leary, Connor, Fletcher, James, Yuile, Alexander, Xu, Wen, Ladwa, Rahul, McGrath, Margaret, Pavlakis, Nick, Hughes, Brett, McCaffery, Elizabeth and O'Byrne, Kenneth (2020). Limited benefit of adjuvant chemotherapy in resected Epidermal Growth Factor Receptor (EGFR) positive non-small cell lung cancer (NSCLC). Medical Oncology Group of Australia Annual Scientific Meeting, Virtual, Australia, 14-21 August 2020. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.
O'Byrne, Kenneth John, Kapeleris, Joanna, Kulasinghe, Arutha, Warkiani, Majid E., O'Leary, Connor Gerard, Ladwa, Rahul, Vela, Ian, Leo, Paul, Sternes, Peter and Punyadeera, Chamindie (2020). Culture of circulating tumour cells derived from non-small cell lung cancer. 2020 ASCO Annual Meeting, Online, 30 May 2020. Alexandria, VA USA: American Society of Clinical Oncology. doi: 10.1200/jco.2020.38.15_suppl.e21692
Goodman, Steven , Patford, Shaun , Ladwa, Rahul , Smith, Jye , Wyld, David and Pattison, David A. (2018). Validation of Abbreviated 177Lu-DOTATATE Renal and Lesional Dosimetry Protocol using Quantitative SPECT. 12th Congress of the World Federation of Nuclear Medicine and Biology., Melbourne Australia, 20-24 April 2018.
Ladwa, R., Pattison, D., Smith, J., Goodman, S., Burge, M., Rose, S., Dowson, N. and Wyld, D. (2018). Positron Emission Tomography (PET) predictors of tumor response to Peptide Receptor Radionuclide Therapy (PRRT) in metastatic Neuroendocrine Tumors (NET). 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 7-9 March 2018. Basel, Switzerland: S. Karger AG.
Ladwa, R., Pattison, D., Smith, J., Goodman, S., Burge, M., Rose, S., Dowson, N. and Wyld, D. (2018). Tumor absorbed dosimetry and response of radionuclide therapy in metastatic neuroendocrine tumor. 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 7-9 March 2018. Basel, Switzerland: S. Karger AG.
Ladwa, R., Pattison, D., Smith, J., Goodman, S., Burg, M., Rose, S., Dowson, N. and Wyld, D. (2018). Pretherapeutic predictors of tumor absorbed dosimetry in radionuclide therapy for metastatic neuroendocrine tumors. 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 7-9 March 2018. Basel, Switzerland: S. Karger AG.
Ladwa, R. and Eastgate, M. (2017). Exploring attitudes and barriers to research in medical oncology training. Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, Real World Oncology: Translating Discovery in to Practice, Pullman Hotel, Albert Park, Melbourne, VIC, 2-4 August 2017. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12729
Pathmanathan, Shivanshan, Ladwa, Rahul and Sanmugarajah, Jasotha (2016). An Update of the Tolerability and Feasibility of Newer Adjuvant Chemotherapy in Older Patients with Breast Cancer. HOBOKEN: WILEY-BLACKWELL.
Atkinson, V. G. and Ladwa, R. (2016). Complete responders to anti-PD1 antibodies. What happens when we stop?. OXFORD: OXFORD UNIV PRESS. doi: 10.1093/annonc/mdw379.11
Peters, G., Smith, D., Rasool, M., Ladwa, R., Hughes, B. and Lwin, Z. (2016). Lean Thinking: Exploring Overhead and Supplementary Tasks (Ost) in Cancer Care (Cc) in the Oncology Outpatient Encounter (Ooe). HOBOKEN: WILEY-BLACKWELL.
Ladwa, R., Xu, W., Tani, D., Wockener, L., Williamson, K., Lwin, Z., Ritchie, A., Steinke, K. and Hughes, B. (2016). The Significance of Pulmonary Nodules in Head and Neck Cancer. HOBOKEN: WILEY-BLACKWELL.
Ladwa, R., McCaffrey, E., Miles, K. and O'Byrne, K. (2016). An Unusual Case of Peritoneal Metastasis From Prostate Cancer. HOBOKEN: WILEY-BLACKWELL.
Ladwa, R., Andelkovic, V. and Atkinson, V. (2016). Pembrolizumab for metastatic melanoma: results of the complete responders on the named patient access program. Implementation + Innovation in Immunotherapy, Gold Coast, QLD, Australia, 3-5 August 2016. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12542
Ladwa, Rahul, Burge, Matthew and Wyld, David (2016). A single center experience of cardiac metastasis from neuroendocrine tumors (net). COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646
Ladwa, Rahul, Chern, Boris, Sanmugarajah, Jasotha and Wyld, David (2016). A prospective 2-year experience of a medical oncology advanced trainee in Queensland. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing.
Ladwa, R., Lyle, M., Wyld, D. and Burge, M. (2016). The Difficulties of Response Assessment after Peptide Receptor Radionucleotide Therapy (PRRT): An Unusual Case of Symptomatic Pseudoprogression. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725
Ladwa, R., Burge, M. and Wyld, D. (2016). A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET). 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725
Ladwa, R., Peters, G. and Bigby, K. (2014). A Retrospective Audit of the Prevalence of Cardiovascular Risk and Metabolic Syndrome in Patients with Treated Testicular Germ Cell Tumours. HOBOKEN: WILEY-BLACKWELL.
Preprint
Monkman, James, Kim, Honesty, Mayer, Aaron, Mehdi, Ahmed, Matigian, Nicholas, Cumberbatch, Marie, Bhagat, Milan, Ladwa, Rahul, Mueller, Scott N., Adams, Mark N., O’Byrne, Ken and Kulasinghe, Arutha (2021). IL-2 stromal signatures dissect immunotherapy response groups in nonsmall cell lung cancer (NSCLC). doi: 10.1101/2021.08.05.21261528
Thesis
Ladwa, Rahul (2020). Predictors of dosimetry and outcome to peptide receptor radionuclide therapy in metastatic neuroendocrine tumour. MPhil Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/uql.2020.552